Redeye: Powercell - Making progress in multiple areas
21 juli, 08:13
21 juli, 08:13
Redeye remains confident on the case although Q2 numbers came in a little shy of our expectations. Adjusted for IP/royalty revenues from the Bosch, sales grew ~12% Y/Y. But we are encouraged by the strong news flow lately where Powercell has signed several important deals with significant future potential. Also, the current order backlog is substantial suggesting a strong H2’25.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
Attachments
21 juli, 08:13
Redeye remains confident on the case although Q2 numbers came in a little shy of our expectations. Adjusted for IP/royalty revenues from the Bosch, sales grew ~12% Y/Y. But we are encouraged by the strong news flow lately where Powercell has signed several important deals with significant future potential. Also, the current order backlog is substantial suggesting a strong H2’25.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
Attachments
ECB
Analyser
Rapportperioden
Kryptovalutor
ECB
Analyser
Rapportperioden
Kryptovalutor
1 DAG %
Senast
Börsen idag
Igår, 17:47
Positivt på Stockholmsbörsen – Astra Zeneca lyfter efter positiva studieresultat
Integrum
Igår, 14:50
Budet på Integrum: Rekordhög premie
OMX Stockholm 30
1 DAG %
Senast
2 600,22